WATERTOWN, Mass.--(BUSINESS WIRE)--Syros Pharmaceuticals, the leader in the discovery and development of novel gene control therapies, announced today that Chief Executive Officer Nancy Simonian, M.D., has been appointed to the Biotechnology Industry Organization’s (BIO) Emerging Companies Section Governing Board.
Dr. Simonian will join with other industry leaders to help shape a policy and legislative agenda for BIO that promotes the needs of emerging companies.
Help employers find you! Check out all the jobs and post your resume.
Dr. Simonian will join with other industry leaders to help shape a policy and legislative agenda for BIO that promotes the needs of emerging companies.
Help employers find you! Check out all the jobs and post your resume.
